Ardent Health vs Surgery Partners
ARDT and SGRY side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ARDT and SGRY compare
Surgery Partners is the larger company, worth 1.8 times as much as Ardent Health ($3.0B against $1.7B).
Surgery Partners grew revenue faster over the last twelve months (4.0% versus 3.3% for Ardent Health).
Ardent Health keeps more of each dollar of sales as profit, with a net margin of 1.2% compared with −2.6% at Surgery Partners.
Ardent Health scores higher on the StockData Score (8 against 6 for Surgery Partners), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ARDT | SGRY |
|---|---|---|
| Size and price | ||
| Market cap | $1.7B | $3.0B |
| Share price | $12.03 | $23.21 |
| Change, 1 year | −19.9% | 2.0% |
| Change, 5 years | – | −53.7% |
| Beta (5Y) | 0.56 | 1.64 |
| Employees | 25K | 16K |
| StockData Score | ||
| Total score | 8 (better) | 6 |
| Valuation score | 4 (better) | 2 |
| Growth score | 0 | 0 |
| Performance score | 2 | 2 |
| Health score | 2 | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 21.9× | – |
| P/S | 0.3× (better) | 0.9× |
| P/B | 1.3× (better) | 1.8× |
| EV/EBITDA | 6.6× (better) | 14.3× |
| P/FCF | – | 16.2× |
| FCF yield | – | 6.2% |
| Fair value | $18.80 | $21.97 |
| Margin of safety | 36.0% (better) | −5.7% |
| Growth | ||
| Revenue growth (TTM) | 3.3% | 4.0% (better) |
| Revenue growth, 5Y average | – | 12.2% |
| Net income growth (TTM) | −69.3% | – |
| EPS growth (TTM) | −69.6% | – |
| Profitability | ||
| Operating margin | – | 11.4% |
| Net margin | 1.2% (better) | −2.6% |
| FCF margin | – | 5.6% |
| Return on equity | 6.0% (better) | −5.2% |
| Return on invested capital | – | 5.9% |
| Financial health | ||
| Debt / equity | 0.82 (better) | 2.25 |
| Net debt / EBITDA | 1.01 (better) | 6.30 |
| Current ratio | 2.10 (better) | 1.95 |
| Altman Z-score | 1.89 (better) | 0.87 |
| Piotroski F-score | 6 (better) | 4 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 76.9% | 121% |
| Held by insiders | 78.9% | 85.9% |
| Insider net buying, 12 months | $186K (better) | −$979K |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 15.6% | 77.9% |
Go deeper
- ARDT stock overview
- ARDT income statement
- ARDT valuation and score
- SGRY stock overview
- SGRY income statement
- SGRY valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.